Results 241 to 250 of about 29,745,998 (266)

VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis

Cell Research, 2010
Luqing Zhang, Yulong He, Masabumi Shibuya   +2 more
exaly  

Relevanz des VEGFR-1 Aktivierungsweges für die Kolonkarzinommetastasierung

Zeitschrift für Gastroenterologie, 2015
N Simiantonaki, C Jayasinghe, C Kirkpatrick   +2 more
openaire   +1 more source

Soluble VEGFR‐1: A new biomarker of sorafenib‐related hypertension

The Journal of Clinical Pharmacology, 2014
A. Thomas‐Schoemann, B. Blanchet, P. Boudou‐Rouquette, J.L. Golmard, G. Noé, C. Chenevier‐Gobeaux, C. Lebbe, C. Pages, J.P. Durand, J. Alexandre, F. Goldwasser, J. Guibourdenche, M. Vidal   +12 more
openaire   +1 more source

Functional significance of VEGFR‐2 on ovarian cancer cells

International Journal of Cancer, 2009
Robert L Coleman, Anil Sood
exaly  

Comparative Structure‐Function Analysis of VEGFR‐1 and VEGFR‐2

Annals of the New York Academy of Sciences, 2003
Nader Rahimi
exaly  

Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors

European Journal of Medicinal Chemistry, 2014
Stefan Laufer, Maria Leticia de Castro Barbosa, Lidia Moreira Lima   +2 more
exaly  

SOLUBLE VEGFR-1 VARIANTS FOR DIAGNOSIS OF PREECLAMPSIA

2015
SELLA-TAVOR OSNAT, POLLOCK SARAH, COJOCARU GAD S, NOVIK AMIT, BAZAK LILY, TSYPKIN ELENA, WALLACH SHIRA, SAMEAH-GREENWALD SHIRLEY   +7 more
openaire   +2 more sources

The role of the VEGF-C/VEGFR-3 axis in cancer progression

British Journal of Cancer, 2006
Mien-Chie Hung, M-L Kuo, C-J Yen
exaly  

Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors

European Journal of Medicinal Chemistry, 2010
Yangmee Kim, Ki-Woong Jeong
exaly  

Design and discovery of 4-anilinoquinazoline-urea derivatives as dual TK inhibitors of EGFR and VEGFR-2

European Journal of Medicinal Chemistry, 2017
Yungen Xu, Liping Sun
exaly